{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T17:29:28Z","timestamp":1777742968812,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06431-z","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:34:14Z","timestamp":1777462454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aquablation versus AEEP for BPH: technique, outcomes, and the evolving surgical landscape \u2013 an EAU endourology perspective"],"prefix":"10.1007","volume":"44","author":[{"given":"Mohammed Taher","family":"Aldoukhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Henrique Bitar","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem","family":"Bhojani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Elterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"3","key":"6431_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132(3):474\u2013479. https:\/\/doi.org\/10.1016\/s0022-5347(17)49698-4","journal-title":"J Urol Sep"},{"issue":"6","key":"6431_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099\u20131109. https:\/\/doi.org\/10.1016\/j.eururo.2014.12.038","journal-title":"Eur Urol Jun"},{"issue":"Suppl 9","key":"6431_CR3","first-page":"S3","volume":"7","author":"CG Roehrborn","year":"2005","unstructured":"Roehrborn CG (2005) Benign prostatic hyperplasia: an overview. Rev Urol 7(Suppl 9):S3\u2013s14","journal-title":"Rev Urol"},{"issue":"7","key":"6431_CR4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1464-410X.2010.09993.x","volume":"108","author":"DE Irwin","year":"2011","unstructured":"Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 108(7):1132\u20131138. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09993.x","journal-title":"BJU Int Oct"},{"issue":"S1","key":"6431_CR5","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1089\/end.2017.0710","volume":"32","author":"ME Rivera","year":"2018","unstructured":"Rivera ME, Lingeman JE, Krambeck AE (2018) Holmium laser enucleation of the prostate. J Endourol 32(S1):S7\u2013s9. https:\/\/doi.org\/10.1089\/end.2017.0710","journal-title":"J Endourol May"},{"issue":"5","key":"6431_CR6","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","volume":"185","author":"KT McVary","year":"2011","unstructured":"McVary KT, Roehrborn CG, Avins AL et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793\u20131803. https:\/\/doi.org\/10.1016\/j.juro.2011.01.074","journal-title":"J Urol May"},{"issue":"1","key":"6431_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eururo.2007.08.036","volume":"53","author":"RM Kuntz","year":"2008","unstructured":"Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol Jan 53(1):160\u2013166. https:\/\/doi.org\/10.1016\/j.eururo.2007.08.036","journal-title":"Eur Urol Jan"},{"key":"6431_CR8","unstructured":"EAU Guidelines Edn. April 2024 (presented at the EAU Annual Congress Paris) doi:ISBN 978-94-92671-23-3"},{"issue":"4","key":"6431_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.eururo.2007.04.052","volume":"53","author":"PJ Gilling","year":"2008","unstructured":"Gilling PJ, Aho TF, Frampton CM, King CJ, Fraundorfer MR (2008) Holmium laser enucleation of the prostate: results at 6 years. Eur Urol 53(4):744\u2013749. https:\/\/doi.org\/10.1016\/j.eururo.2007.04.052","journal-title":"Eur Urol Apr"},{"issue":"5","key":"6431_CR10","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"P Gilling","year":"2018","unstructured":"Gilling P, Barber N, Bidair M et al (2018) WATER: A double-blind, randomized, controlled trial of aquablation (\u00ae) vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol 199(5):1252\u20131261. https:\/\/doi.org\/10.1016\/j.juro.2017.12.065","journal-title":"J Urol May"},{"issue":"1","key":"6431_CR11","first-page":"10960","volume":"29","author":"PJ Gilling","year":"2022","unstructured":"Gilling PJ, Barber N, Bidair M et al (2022) Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol 29(1):10960\u201310968","journal-title":"Can J Urol Feb"},{"issue":"2","key":"6431_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.euf.2026.01.006","volume":"12","author":"M Ritter","year":"2026","unstructured":"Ritter M, Stein J, Barber N et al (2026) WATER III: A prospective, partially randomized trial of aquablation therapy versus transurethral laser enucleation of the prostate for treatment of lower urinary tract symptoms. Eur Urol Focus 12(2):266\u2013274. https:\/\/doi.org\/10.1016\/j.euf.2026.01.006","journal-title":"Eur Urol Focus Mar"},{"issue":"1","key":"6431_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.23736\/s2724-6051.24.05871-3","volume":"77","author":"J Justo Quintas","year":"2025","unstructured":"Justo Quintas J, Garc\u00eda Rojo E, Garc\u00eda G\u00f3mez B et al (2025) Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study. Minerva Urol Nephrol 77(1):111\u2013119. https:\/\/doi.org\/10.23736\/s2724-6051.24.05871-3","journal-title":"Minerva Urol Nephrol Feb"},{"key":"6431_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.euros.2021.01.004","volume":"25","author":"DD Nguyen","year":"2021","unstructured":"Nguyen DD, Barber N, Bidair M et al (2021) WATER versus WATER II 2-year update: comparing aquablation therapy for benign prostatic hyperplasia in 30-80-cm(3) and 80-150-cm(3) Prostates. Eur Urol Open Sci 25:21\u201328. https:\/\/doi.org\/10.1016\/j.euros.2021.01.004","journal-title":"Eur Urol Open Sci Mar"},{"issue":"2","key":"6431_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/bco2.121","volume":"3","author":"KC Zorn","year":"2022","unstructured":"Zorn KC, Bidair M, Trainer A et al (2022) Aquablation therapy in large prostates (80\u2013150\u00a0cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results. BJUI Compass 3(2):130\u2013138. https:\/\/doi.org\/10.1002\/bco2.121","journal-title":"BJUI Compass Mar"},{"issue":"1","key":"6431_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00345-024-05439-7","volume":"2025\/01\/24","author":"JG Porto","year":"2025","unstructured":"Porto JG, Bhatia AM, Bhat A et al (2025) Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century. World J Urol 43(1): 85. https:\/\/doi.org\/10.1007\/s00345-024-05439-7","journal-title":"World J Urol"},{"issue":"2","key":"6431_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0022-5347(17)40731-2","volume":"141","author":"WK Mebust","year":"1989","unstructured":"Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 141(2):243\u2013247. https:\/\/doi.org\/10.1016\/s0022-5347(17)40731-2","journal-title":"J Urol Feb"},{"issue":"5","key":"6431_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol 50(5):969\u2013979 discussion 980. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.042","journal-title":"Eur Urol Nov"},{"issue":"6","key":"6431_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/end.2000.14.529","volume":"14","author":"PJ Gilling","year":"2000","unstructured":"Gilling PJ, Kennett KM, Fraundorfer MR (2000) Holmium laser enucleation of the prostate for glands larger than 100\u00a0g: an endourologic alternative to open prostatectomy. J Endourol 14(6):529\u2013531. https:\/\/doi.org\/10.1089\/end.2000.14.529","journal-title":"J Endourol Aug"},{"issue":"11","key":"6431_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1089\/end.2022.0262","volume":"36","author":"M Himmler","year":"2022","unstructured":"Himmler M, Gr\u00fcne B, von Hardenberg J et al (2022) Switching lasers: learning curve of holmium laser enucleation of the prostate in surgeons experienced in thulium laser enucleation of the prostate. J Endourol 36(11):1444\u20131451. https:\/\/doi.org\/10.1089\/end.2022.0262","journal-title":"J Endourol Nov"},{"issue":"5","key":"6431_CR21","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/s0022-5347(05)00983-3","volume":"175","author":"A Briganti","year":"2006","unstructured":"Briganti A, Naspro R, Gallina A et al (2006) Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol 175(5):1817\u20131821. https:\/\/doi.org\/10.1016\/s0022-5347(05)00983-3","journal-title":"J Urol May"},{"key":"6431_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-025-01087-6","author":"A Bettencourt","year":"2025","unstructured":"Bettencourt A, Wu J, Borrell JA et al (2025) Ejaculatory function after robotic waterjet ablation for the treatment of benign prostatic hyperplasia: a systematic review. Int J Impot Res https:\/\/doi.org\/10.1038\/s41443-025-01087-6","journal-title":"Int J Impot Res"},{"key":"6431_CR23","doi-asserted-by":"publisher","unstructured":"Berjaoui MB, Nguyen D-D, Almousa S et al (2024) WATER versus WATER II 5-year update: comparing Aquablation therapy for benign prostatic hyperplasia in 30\u201380-cm3 and 80\u2013150-cm3 prostates. BJUI Compass. 5(11):1137\u20131147. https:\/\/doi.org\/10.1002\/bco2.430","DOI":"10.1002\/bco2.430"},{"issue":"1","key":"6431_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/ju.0000000000003483","volume":"210","author":"N Bhojani","year":"2023","unstructured":"Bhojani N, Bidair M, Kramolowsky E et al (2023) Aquablation Therapy in Large Prostates (80\u2013150 mL) for lower urinary tract symptoms due to Benign Prostatic Hyperplasia: final WATER II 5-year clinical trial results. J Urol 210(1):143\u2013153. https:\/\/doi.org\/10.1097\/ju.0000000000003483","journal-title":"J Urol Jul"},{"issue":"4","key":"6431_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.eururo.2012.01.010","volume":"61","author":"TR Herrmann","year":"2012","unstructured":"Herrmann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS (2012) EAU guidelines on laser technologies. Eur Urol 61(4):783\u2013795. https:\/\/doi.org\/10.1016\/j.eururo.2012.01.010","journal-title":"Eur Urol Apr"},{"issue":"2","key":"6431_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/bju.14703","volume":"124","author":"M Desai","year":"2019","unstructured":"Desai M, Bidair M, Zorn KC et al (2019) Aquablation for benign prostatic hyperplasia in large prostates (80\u2013150 mL): 6-month results from the WATER II trial. BJU Int 124(2):321\u2013328. https:\/\/doi.org\/10.1111\/bju.14703","journal-title":"BJU Int Aug"},{"issue":"5","key":"6431_CR27","first-page":"11650","volume":"30","author":"K Oumedjbeur","year":"2023","unstructured":"Oumedjbeur K, Corsi NJ, Bouhadana D et al (2023) Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate 50\u201380 mL. Can J Urol 30(5):11650\u201311658","journal-title":"Can J Urol Oct"},{"issue":"1","key":"6431_CR28","doi-asserted-by":"publisher","first-page":"e000090","DOI":"10.1136\/bmjsit-2021-000090","volume":"3","author":"D Elterman","year":"2021","unstructured":"Elterman D, Gilling P, Roehrborn C et al (2021) Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies. BMJ Surg Interv Health Technol 3(1):e000090. https:\/\/doi.org\/10.1136\/bmjsit-2021-000090","journal-title":"BMJ Surg Interv Health Technol"},{"issue":"2","key":"6431_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.eururo.2011.10.009","volume":"61","author":"T Bach","year":"2012","unstructured":"Bach T, Muschter R, Sroka R et al (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61(2):317\u2013325. https:\/\/doi.org\/10.1016\/j.eururo.2011.10.009","journal-title":"Eur Urol Feb"},{"issue":"5","key":"6431_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1089\/end.2012.0505","volume":"27","author":"L Yin","year":"2013","unstructured":"Yin L, Teng J, Huang CJ, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604\u2013611. https:\/\/doi.org\/10.1089\/end.2012.0505","journal-title":"J Endourol May"},{"issue":"10","key":"6431_CR31","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/bjs.5916","volume":"94","author":"A Tan","year":"2007","unstructured":"Tan A, Liao C, Mo Z, Cao Y (2007) Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 94(10):1201\u20131208. https:\/\/doi.org\/10.1002\/bjs.5916","journal-title":"Br J Surg Oct"},{"issue":"12","key":"6431_CR32","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.3390\/medicina61122076","volume":"61","author":"P Triantafyllou","year":"2025","unstructured":"Triantafyllou P, Arseniou P, Katsimperis S et al (2025) Complication profile and safety outcomes of aquablation in the management of BPH. Medicina 61(12):2076","journal-title":"Medicina"},{"issue":"9","key":"6431_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/pros.24697","volume":"84","author":"C Roper","year":"2024","unstructured":"Roper C, Slade A, Caras R, Shelton T, Rivera M (2024) Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate. Prostate 84(9):791\u2013796. https:\/\/doi.org\/10.1002\/pros.24697","journal-title":"Prostate Jun"},{"issue":"2","key":"6431_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4111\/kju.2012.53.2.104","volume":"53","author":"MS Jeong","year":"2012","unstructured":"Jeong MS, Ha SB, Lee CJ, Cho MC, Kim SW, Paick J-S (2012) Serial changes in sexual function following holmium laser enucleation of the prostate: a short-term follow-up study. Korean J Urol 53(2):104\u2013108","journal-title":"Korean J Urol 2\/"},{"issue":"10","key":"6431_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4111\/kju.2010.51.10.688","volume":"51","author":"J Bae","year":"2010","unstructured":"Bae J, Oh SJ, Paick JS (2010) The learning curve for holmium laser enucleation of the prostate: a single-center experience. Korean J Urol 51(10):688\u2013693. https:\/\/doi.org\/10.4111\/kju.2010.51.10.688","journal-title":"Korean J Urol Oct"},{"issue":"7","key":"6431_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1464-410X.2004.04765.x","volume":"93","author":"MJ Speakman","year":"2004","unstructured":"Speakman MJ, Kirby RS, Joyce A, Abrams P, Pocock R (2004) Guideline for the primary care management of male lower urinary tract symptoms. BJU Int 93(7):985\u2013990. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.04765.x","journal-title":"BJU Int May"},{"issue":"5","key":"6431_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.eururo.2007.04.074","volume":"52","author":"EA Elzayat","year":"2007","unstructured":"Elzayat EA, Elhilali MM (2007) Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52(5):1465\u20131471. https:\/\/doi.org\/10.1016\/j.eururo.2007.04.074","journal-title":"Eur Urol Nov"},{"issue":"6","key":"6431_CR38","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s12325-019-00952-3","volume":"36","author":"P Gilling","year":"2019","unstructured":"Gilling P, Barber N, Bidair M et al (2019) Two-year outcomes after Aquablation compared to TURP: efficacy and ejaculatory improvements sustained. Adv Ther 36(6):1326\u20131336. https:\/\/doi.org\/10.1007\/s12325-019-00952-3","journal-title":"Adv Ther Jun"},{"issue":"5","key":"6431_CR39","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/s0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ Jr., O\u2019Leary MP et al (1992) The American urological association symptom index for benign prostatic hyperplasia. The measurement committee of the American urological association. J Urol 148(5):1549\u20131557 discussion 1564. https:\/\/doi.org\/10.1016\/s0022-5347(17)36966-5","journal-title":"J Urol Nov"},{"key":"6431_CR40","doi-asserted-by":"publisher","unstructured":"Samenezhad S, Rafighi D (2025) The Role of Artificial Intelligence in Advancing Urologic Care: From Diagnostics to Therapeutics. Surg Pract Sci 11. https:\/\/doi.org\/10.1016\/j.sipas.2025.100322. \/29\/ 2025:100322","DOI":"10.1016\/j.sipas.2025.100322"},{"key":"6431_CR41","doi-asserted-by":"publisher","unstructured":"Elwyn G, Frosch D, Thomson R et al (Oct 2012) Shared decision making: a model for clinical practice. J Gen Intern Med 27(10):1361\u20131367. https:\/\/doi.org\/10.1007\/s11606-012-2077-6","DOI":"10.1007\/s11606-012-2077-6"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06431-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:34:16Z","timestamp":1777462456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06431-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6431"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06431-z","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Elterman is a consultant\/investigator for Boston Scientific, Procept Biorobotics, Olympus, Urotronic, Prodeon, and Zenflow. Dr. Chughtai is a consultant for Boston Scientific, Olympus, Laborie, Prodeon Medical, Teleflex. Dr. Bhojani is a consultant\/investigator for Boston Scientific, Procept BioRobotics, and Olympus. Other authors have no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required for this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"330"}}